ZA945093B - Use of cephem derivatives as anti-metastatic agents - Google Patents

Use of cephem derivatives as anti-metastatic agents

Info

Publication number
ZA945093B
ZA945093B ZA945093A ZA945093A ZA945093B ZA 945093 B ZA945093 B ZA 945093B ZA 945093 A ZA945093 A ZA 945093A ZA 945093 A ZA945093 A ZA 945093A ZA 945093 B ZA945093 B ZA 945093B
Authority
ZA
South Africa
Prior art keywords
pct
defined above
organic radical
sec
cephem derivatives
Prior art date
Application number
ZA945093A
Other languages
English (en)
Inventor
Marco Alpegiani
Pierluigi Bissolino
Ettore Perrone
Enrico Pesenti
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ZA945093B publication Critical patent/ZA945093B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ZA945093A 1993-07-14 1994-07-13 Use of cephem derivatives as anti-metastatic agents ZA945093B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314562A GB9314562D0 (en) 1993-07-14 1993-07-14 Use of cephem derivatives as anti-metastatic agents

Publications (1)

Publication Number Publication Date
ZA945093B true ZA945093B (en) 1995-02-22

Family

ID=10738806

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945093A ZA945093B (en) 1993-07-14 1994-07-13 Use of cephem derivatives as anti-metastatic agents

Country Status (15)

Country Link
US (1) US5777104A (xx)
EP (1) EP0708779B1 (xx)
JP (1) JPH09500118A (xx)
KR (1) KR960703599A (xx)
AT (1) ATE176235T1 (xx)
AU (1) AU680526B2 (xx)
CA (1) CA2167194A1 (xx)
DE (1) DE69416311T2 (xx)
ES (1) ES2128572T3 (xx)
GB (1) GB9314562D0 (xx)
HU (1) HUT72739A (xx)
IL (1) IL110273A0 (xx)
PL (1) PL312582A1 (xx)
WO (1) WO1995002603A2 (xx)
ZA (1) ZA945093B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513818D0 (en) * 1995-07-06 1995-09-06 Pharmacia Spa 7,7-Disubstituted cephem-4-ketones
WO1997007805A1 (en) * 1995-08-31 1997-03-06 Smithkline Beecham Corporation Interleukin converting enzyme and apoptosis
JPH11511463A (ja) * 1995-08-31 1999-10-05 スミスクライン・ビーチャム・コーポレイション インターロイキン変換酵素およびアポプトーシス
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
EP2926815A1 (en) * 2014-04-03 2015-10-07 Institut Curie New derivatives of cephalosporin for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0383987A (ja) * 1989-08-26 1991-04-09 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩類
AU649275B2 (en) * 1990-11-06 1994-05-19 Bristol-Myers Squibb Company Prodrugs for beta-lactamase and uses thereof
GB2266525A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted cephalosporin sulfone compositions useful in the treatment of leukemia

Also Published As

Publication number Publication date
WO1995002603A2 (en) 1995-01-26
IL110273A0 (en) 1994-10-21
HUT72739A (en) 1996-05-28
EP0708779A1 (en) 1996-05-01
CA2167194A1 (en) 1995-01-26
KR960703599A (ko) 1996-08-31
GB9314562D0 (en) 1993-08-25
US5777104A (en) 1998-07-07
HU9503852D0 (en) 1996-02-28
PL312582A1 (en) 1996-04-29
ATE176235T1 (de) 1999-02-15
JPH09500118A (ja) 1997-01-07
AU7227794A (en) 1995-02-13
ES2128572T3 (es) 1999-05-16
DE69416311T2 (de) 1999-08-26
AU680526B2 (en) 1997-07-31
WO1995002603A3 (en) 1995-03-09
EP0708779B1 (en) 1999-01-27
DE69416311D1 (de) 1999-03-11

Similar Documents

Publication Publication Date Title
DE69327541D1 (en) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
TW260669B (xx)
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
AU3345595A (en) 3-benzoyl benzofuran derivatives as thyroid hormone antagonists
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
AU5711594A (en) Piperazine derivatives as 5-ht antagonists
EP0700291A4 (en) 4-AZASTEROIDS SUBSTITUTED IN THE 15-POSITION
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
EP0572635A4 (fr) Nouveaux composes a structure guanidique et composition pharmaceutique les contenant.
GB9306886D0 (en) Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
HU9503852D0 (en) Use of cephem derivatives as anti-metastatic agents
GR3021736T3 (en) N-substitued 3-azabicyclo 3.2.0]heptane derivatives useful as neuroleptic agents etc.
GR3030506T3 (en) 1-azaadamantane derivatives as 5-ht agonists or antagonists.
AU5674894A (en) Azanoradamantanes
ES8304973A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos.
PL310553A1 (en) Benzopyranes as agents opening potassium canals
CA2129813A1 (en) 5-aminoflavone derivatives
DE69320488D1 (de) Azaspiroalkan-derivate als therapeutika